cms_WY: 23
Data source: Big Local News · About: big-local-datasette
rowid | facility_name | facility_id | address | city | state | zip | inspection_date | deficiency_tag | scope_severity | complaint | standard | eventid | inspection_text | filedate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
23 | GRANITE REHABILITATION AND WELLNESS | 535013 | 3128 BOXELDER DRIVE | CHEYENNE | WY | 82001 | 2017-10-04 | 329 | D | 0 | 1 | GX9L11 | **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on medical record review and staff interview, the facility failed to ensure the medication regimen for 1 of 20 sample residents (#90) was free from unnecessary drugs. The findings were: 1. Review of the 7/18/17 quarterly MDS assessment showed resident #90 had severe cognitive impairment and [DIAGNOSES REDACTED]. Review of the care plan, revised on 8/1/17, showed problems included dementia, feelings of depression, self isolation and verbal outbursts of screaming when ambulating or with cares. This review also showed interventions included interdisciplinary team and physician review for reduction of dosage every 3 months and report new behaviors, and worsening or violent behaviors. Review of the quarterly Psychoactive Drug and Behavior Medication Review Form, dated 6/20/17, showed the interdisciplinary team noted the resident had increased outbursts with agitation and anxiety. Review of the psychotherapy progress notes, dated 8/25/17, 9/1/17, 9/7/17, and 9/15/17 showed the resident reported depressed mood daily, little to no interest in most things, and has feelings of worthlessness. Review of the physician's orders [REDACTED]. Review of the Consultant Pharmacist Medication Regimen Reviews dated 2/13/17 - 2/21/17 and 9/25/17-9/26/17 showed the pharmacist recommended the physician review the medications for a gradual dose reduction and document a risk versus benefits rationale if the physician determined the reduction should not be done. Review of the pharmacy consultation report, dated 2/27/17, and the Psychoactive Drug and Behavior Medication Review Form dated 6/20/17 showed the physician response each time was for the medication review to be done by the psychiatrist. Interview with the DON on 10/4/17 at 11:10 AM revealed a psychiatrist was not available at the time the pharmacist made his initial recommendation. She further stated the review for the gradual dose reduction had not been done because they did not have a psychiatrist until (MONTH) (YEAR). | 2020-09-01 |